Fusion Pharmaceuticals Inc.
FUSN · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$95 | -$88 | -$81 | -$78 |
| Dep. & Amort. | $1 | $1 | $1 | $0 |
| Deferred Tax | $1 | -$3 | -$1 | -$1 |
| Stock-Based Comp. | $12 | $11 | $9 | $3 |
| Change in WC | -$1 | $4 | -$15 | $6 |
| Other Non-Cash | -$0 | $2 | $12 | $40 |
| Operating Cash Flow | -$82 | -$73 | -$76 | -$30 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$2 | -$1 | -$1 |
| Net Acquisitions | $39 | -$25 | -$39 | -$10 |
| Inv. Purchases | -$231 | -$165 | -$172 | -$219 |
| Inv. Sales/Matur. | $192 | $190 | $212 | $10 |
| Other Inv. Act. | -$39 | $25 | $39 | $10 |
| Investing Cash Flow | -$43 | $23 | $38 | -$210 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $142 | $6 | $0 | $198 |
| Stock Repurch. | $0 | $1 | $0 | -$72 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $142 | $41 | $0 | $266 |
| Financing Cash Flow | $142 | $41 | $0 | $266 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $18 | -$9 | -$38 | $25 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44 | $55 | $92 | $67 |
| End Cash | $62 | $45 | $55 | $92 |
| Free Cash Flow | -$86 | -$75 | -$77 | -$31 |